Serologic studies at Fort Dix suggested that >200 soldiers had been infected and that person-to-person transmission had occurred. Centers for Disease Control and Prevention. CDC considered that its appropriate main line of communication was to states and local health departments, believing that they were best placed to communicate with the public. However, this series of events was interpreted by the media and others as an attempt by the government to "stimulate" NIIP. The 2009 H1N1 swine flu vaccine is made exactly the same way as the seasonal flu vaccine, by the same manufacturers using the same materials -- except for one shiny new piece. A moratorium on the use of the influenza vaccines was announced on December 16; it effectively ended NIIP of 1976. In the United States, the Vaccine Adverse Event Reporting System–the FDA’s voluntary, unsystematic, unmoderated reporting system, where anyone can submit any report claiming whatever they want about a vaccine, such as turning your child into The Hulk–does provide some data about claimed adverse events after the H1N1 shot. It found that there were 138 deaths from an estimated 540,000 cases, or around 26 deaths per 100,000 people. The WHO estimated there would be about 3 billion vaccine doses administered in 12 months. However, as the authors point out, this conclusion is limited by the absence of a. Had H1N1 influenza been transmitted at that time, the small apparent risk of GBS from immunization would have been eclipsed by the obvious immediate benefit of vaccine-induced protection against swine flu. In spite of the obstacles discussed below, NIIP administered a program that immunized 45 million in 10 weeks, which resulted in doubling the level of immunization for persons deemed to be at high risk, rapidly identifying adverse effects, and developing and administering an informed consent form for use in a community-based program. What NIIP did not and could not survive, however, was the second blow, finding cases of Guillain-Barré syndrome (GBS) among persons receiving swine flu immunizations. Though the 2009 flu pandemic primarily affected children and young and middle-aged adults, the impact of the (H1N1)pdm09 virus on the global population during the first year was less severe than that of previous pandemics.
This work was conducted as part of the public health response to pandemic influenza in England, and no additional funding was sought. But subsequent research showed that that was a gross underestimation. Fill with Vaccine! III.
It outlined the problem and presented 4 alternative courses of action.
The principal obstacle was the lack of vaccines. This research has investigated all deaths considered to be related to flu, which may together be expected to provide accurate projections of flu-related mortality rates. The conclusion is clear: the swine flu killed between 151,000 and 579,000 people worldwide in the 2009/2010 flu season. But we do have some numbers to work with. It is possible that the death rates calculated could have some unavoidable inaccuracy. Emerg Infect Dis. Specifically, the following facts were of concern: 1) persons <50 years of age had no antibodies to this new strain; 2) a current interpandemic strain (A/Victoria) of influenza was widely circulating; 3) this early detection of an outbreak caused by A/New Jersey/76/Hsw1N1 (H1N1) provided an opportunity to produce a vaccine since there was sufficient time between the initial isolates and the advent of an expected influenza season to produce vaccine. Man the Harpoons! Influenza pandemic periodicity, virus recycling, and the art of risk assessment. This organizational mode functioned well, a tribute to the lack of interagency jealousies. However, there remains the unavoidable possibility of mortality rates either being slightly underestimated if there have been deaths associated with swine flu where the virus was not recorded as the primary cause of death, or a slight overestimate due to underestimation in the total number of swine flu cases.
In November 2009, the CDC found that of the 46 million H1N1 vaccine doses delivered in the US, there were 3,182 adverse events reported, for a rate of about 0.7 events per 10,000 doses–not significantly different from the season flu vaccine. From August 2009, a separate reporting system has been used for deaths occurring in the community, such as those occurring in the home. The Delphi exercise of Schoenbaum in early fall of 1976 (13) was the most serious scientific undertaking to poll scientists to decide whether or not to continue the program.